NEUROANATOMICAL AND PHYSIOLOGICAL EVIDENCE FOR THE INVOLVEMENT OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE IN THE REGULATION OF THE DISTAL LOBE OF THE FROG PITUITARY
L. Yon et al., NEUROANATOMICAL AND PHYSIOLOGICAL EVIDENCE FOR THE INVOLVEMENT OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE IN THE REGULATION OF THE DISTAL LOBE OF THE FROG PITUITARY, Journal of neuroendocrinology, 5(3), 1993, pp. 289-296
Pituitary adenylate cyclase-activating polypeptide (PACAP) is a 38 ami
no-acid peptide which belongs to the glucagon/secretin/vasoactive inte
stinal peptide superfamily. The sequence of PACAP is identical in all
mammalian species studied so far but frog PACAP differs by one amino-a
cid from mammalian PACAP. The aim of the present study was to investig
ate the presence of PACAP in the hypothalamo-pituitary complex of the
frog Rana ridibunda and to determine the biological activity of frog P
ACAP on homologous pituitary cells. The distribution of PACAP-containi
ng neurons and fibers was examined by the indirect immunofluorescence
method using an antiserum raised against the N-terminal region of the
peptide. In the hypothalamus, PACAP-immunoreactive perikarya were loca
lized in the preoptic nucleus and the dorsal and ventral infundibular
nuclei. Beaded nerve fibers were observed coursing from the ventral in
fundibular nucleus to the external vascular layer of the median eminen
ce. A dense network of immunoreactive axons terminated in the vicinity
of the capillaries of the hypophysial portal system. The neurointerme
diate lobe and the distal lobe of the pituitary were devoid of immunor
eactive elements. The amount of PACAP-like immunoreactive material in
hypothalamus extracts was measured by radioimmunoassay; the apparent c
oncentration of PACAP was 4.5 ng/mg protein. Synthetic frog PACAP38 an
d PACAP27 induced a similar dose-dependent stimulation of cAMP product
ion in isolated frog distal lobe pituitary fragments (ED50 = 2 x 10(-8
) M). At the maximum dose tested (5 x 10(-6) M), both frog PACAP38 and
PACAP27 produced a 4-fold increase in cAMP production. In contrast, t
he truncated form [Des-His1]frog PACAP38 did not affect adenylate cycl
ase activity demonstrating therefore that the N-terminal histidyl resi
due is essential for the biological activity of the peptide. [Des-His1
]frog PACAP38 did not antagonize the stimulatory effect of frog PACAP3
8 or PACAP27 on cAMP production. Taken together, these data support th
e concept that, in amphibians as in mammals, PACAP may act as a hypoph
ysiotropic neuropeptide.